Document is current
Any future updates will be listed below
-
Authors
Messner, Marc
Mitterwallner, Josef-Martin
Unterhofer, Michael
Wipfler, Peter
Harrer, Andrea
Moser, Tobias
- License Information
-
More Information
Article History
Received: 19 January 2026
Accepted: 18 February 2026
First Online: 13 March 2026
Declarations
:
: Michael Unterhofer received travel support and has participated in meetings sponsored by Alexion Pharmaceuticals, Merck, Neuraxpharm and Novartis. Peter Wipfler has received personal honoraria for lectures and educational activities from Alexion, Biogen, Merck, Neuraxpharm, Novartis, Roche, Sanofi-Genzyme, Teva-Ratiopharm, Janssen-Pharmazeutika, Bristol Myers Squibb and Horizon Therapeutics. Andrea Harrer received lecture honoraria from Merck, travel and research support from BMS. Tobias Moser received travel support, honoraria for presentations or participation on advisory boards from Biogen, BMS, Novartis, Roche, Sanofi, Merck, Stada and Teva. Marc Messner and Josef-Martin Mitterwallner declare no competing interests.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
